Precigen Stock Down 1.2%NASDAQ:PGEN traded down $0.08 during mid-day trading on Tuesday, hitting $6.53. 7,894,080 shares of the company’s stock traded hands, compared to its average volume of 4,504,153. Following the sale, the chief executive officer directly owned 3,768,872 shares of the company’s stock, valued at $22,198,656.08. COO Rutul Shah sold 33,772 shares for approximately $219,500 under a pre-arranged Rule 10b5-1 plan; other executives also sold shares. Precigen Company Profile(Get Free Report)Precigen, Inc (NASDAQ: PGEN) is a biotechnology company focused on the discovery, development and commercialization of genetic medicines.